Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Biruh T Workeneh Image

      Biruh T Workeneh, MD, FASN

      Department of Emergency Medicine, Division of Internal Medicine

      About Dr. Biruh T Workeneh

      Dr. Biruh Workeneh is a provider in the MD Anderson Internal Medicine Center and a Professor in the Section of Nephrology. He is board-certified in Internal Medicine and joined MD Anderson in 2015.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2002University of Texas McGovern Medical School, Houston, Texas, US, MD
      1998University of Texas at Austin, Austin, Texas, US, BA, BA

      Postgraduate Training

      2017-2018Graduate Certificate in Health Care Management, Rice University Business School, Houston, Texas
      2007-2008Post-Doctoral Fellowship, Stanford University, Stanford, California
      2005-2007Clinical Fellowship, Nephrology, Stanford University, Stanford, California
      2002-2005Internship/Residency, University of Texas Medical Branch, Galveston, Texas

      Licenses & Certifications

      2023Mississippi State Board of Medical Licensure
      2023Georgia Composite Medical Board
      2023Oklahoma State Board of Medical Licensure
      2023Alabama Board of Medical Examiners
      2023Arizona Board of Medical Examiners
      2023Washington State Department of Health
      2023Tennessee Board of Medical Examiners
      2023Louisiana State Board of Medical Examiners
      2021Florida Board of Medicine
      2021DEA - Controlled Substance Registration Certificate
      2008Texas Medical Board
      2008American Board of Internal Medicine Certification in Nephrology
      2005American Board of Internal Medicine

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2022

      Assistant Professor, Baylor College of Medicine, Houston, TX, 2008 - 2015

      Administrative Appointments/Responsibilities

      Department of Internal Medicine Wellness Committee Member, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

      Faculty Senate Representative, Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

      Internal Medicine Division Professionalism Ambassador, Center of Professionalism, Support & Success (CPSS), The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

      CoP Dialysis Workgroup Leader, Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020

      Medical Director, Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present

      Other Professional Positions

      Nephrology Attending, Texas Children's Hospital Pavilion for Women, Houston, TX, 2012 - Present

      Nephrology Attending, Park Plaza Hospital, Houston, TX, 2011 - Present

      Nephrology Attending, University General Hospital, Houston, TX, 2011 - Present

      Advisory Board Member, US Renal Care, Houston, TX, 2010 - Present

      Nephrology Attending, The Methodist Hospital, Houston, TX, 2008 - Present

      Nephrology Attending, CHI Baylor St. Luke's Hospital, Houston, TX, 2008 - Present

      Nephrology Attending, Ben Taub General Hospital, Houston, TX, 2008 - Present

      Nephrology Attending Staff, Palo Alto VA Medical Center, Palo Alto, CA, 2007 - 2008

      Nephrology Attending, Livermore VA Medical Center, Livermore, CA, 2007 - 2008

      Hospitalist Staff, Eden Medical Center, Castro Valley, CA, 2007 - 2008

      Hospitalist Staff, Los Gatos Community Hospital, San Jose, CA, 2006 - 2007

      Hospitalist Staff, O'Connor Hospital, San Jose, CA, 2006 - 2007

      Hospitalist Staff, Good Samaritan Hospital, San Jose, CA, 2006 - 2007

      Editorial Activities

      Editorial Committee Member, Journal of Renal Nutrition, 2018 - Present

      Editorial Committee Member, Journal of Renal Nutrition, 2018 - Present

      Review Editor, Frontier in Nephrolopgy, 2016 - 2018

      Honors & Awards

      2024 - PresentBest Subspecialty Teaching Faculty at MD Anderson, Baylor College of Medicine Internal Medicine Residence
      2021Gulf Coast Lupus Foundation of America Multi-Year Award, The University of Texas MD Anderson Cancer Center
      2020Internal Medicine Faculty Excellence Award, Finalist, The University of Texas MD Anderson Cancer Center
      2019Top Performer Award, The University of Texas MD Anderson Cancer Center
      2018 - 2024Bayou City Bean Club, Program Chair, The University of Texas MD Anderson Cancer Center
      2018Controversies in Onconephrology Workgroup Advisor
      2016 - 2018Annual Onco-nephrology Symposium - Chair, The University of Texas MD Anderson Cancer Center
      2015 - 2016Houstonia Magazine Top Doctor, Baylor College of Medicine
      2014 - 2015Power of Professionalism Award, Baylor College of Medicine
      2014 - 2015Super Doctor, Baylor College of Medicine
      2013 - 2014Fulbright and Jaworski Excellence in Teaching Award, Baylor College of Medicine
      2013 - 2014Texas Rising Star, Texas Monthly Magazine (Texas Best Doctors)
      2012 - 2013Press-Ganey Outstanding Physician of the Quarter, Baylor College of Medicine
      2012 - 2013Academy of Distinguished Educators, Baylor College of Medicine
      2011 - 2013Outstanding Teacher Award in Nephrology, Baylor College of Medicine
      2009 - 2024Fellow of the American Society of Nephrology, Baylor College of Medicine
      2002 - 2003Hines Foundation Scholar, University of Texas-Houston Medical School
      2002 - 2003Outstanding Resident, University of Texas Medical Branch at Galveston
      2000 - 2002Vice President Student Inter-Council, University of Texas - Houston Medical School
      1997 - 1998Vice Presidential Research Award, University of Texas at Austin
      1994 - 1995Texas Academic Honors Award, University of Texas at Austin

      Professional Memberships

      Ethiopian Diaspora Trust Fund Executive Board

      2023 - Present

      MD Anderson Faculty Academic Career Development Academy

      2022 - Present

      Gulf Coast Lupus Foundation of America

      2021 - Present

      American Society of Onco-Nephrology

      2021 - Present

      Global Initiative for Better Health

      2014 - Present

      Community of Health (Patient Health and Safety)

      2012 - 2013

      Advisory Board for US Renal Care

      2010 - 2014

      American College of Physicians

      2009 - 2012

      American Society of Nephrology

      2005 - Present

      National Kidney Foundation

      2005 - 2009

      Selected Presentations & Talks

      Local Presentations

      1. 2015. Acute Kidney Injury: Diagnosis, Classification & Management. Invited. Baylor College of Medicine, US.
      2. 2014. Everything You Wanted to Know About Dialysis. Invited. Baylor College of Medicine. Houston, TX, US.
      3. 2014. Kt/V, the 5-syllable Conundrum. Invited. University of Pittsburgh Medical Center. Pittsburgh, PA, US.
      4. 2013. Sickle Cell Nephropathy. Invited. Nephrology Grand Rounds, US.
      5. 2012. Clinicopathologic Conference (discussant). Invited. Baylor College of Medicine. Houston, TX, US.
      6. 2012. Transitioning from Pediatric to Adult Nephrology. Invited. Texas Children's Hospital. Houston, TX, US.
      7. 2008. Clinicopathologic Conference (discussant). Invited. Grand Rounds. Houston, TX, US.
      8. 2008. Glomerular Structure, Number and Function in Aging Cadaveric Donors. Invited. Nephrology Grand Rounds, US.

      Regional Presentations

      1. 2004. Double Trouble: A case of hypernatremia. Invited. Southwest Regional Meeting. Clear Lake, TX, US.

      National Presentations

      1. 2025. Rare Case of Dual Paraneoplastic Endocrinopathies in Small Cell Lung Cancer: Triphasic Electrolyte Presentation. Poster. ASN Kidney Week. Houston, TX, US.
      2. 2025. TRPC6 Inhibition for the Treatment of FSGS: Phase 2 Randomized Controlled Trial of BI 764198. Invited. ASN Kidney Week. Houston, TX, US.
      3. 2025. Kidney Perspective of a Novel Fusion Protein Immune Agent: Anti-PD1/Mutated IL-15 Fusion Protein. Poster. ASN Kidney Week. Houston, TX, US.
      4. 2025. Pegloticase for Tumor Lysis Syndrome. Invited. ASN Kidney Week. Houston, TX, US.
      5. 2025. Efficacy and safety of finerenone in patients with cancer: A FIDELITY subgroup analysis. Poster. NKF 2025 Spring Clinical Meetings. Boston, MA, US.
      6. 2024. CKD of Unknown Etiology (CKDu): Histopathology of the Disease in Patients from Nicaragua. Poster. ASN Kidney Week. San Diego, CA, US.
      7. 2024. A Phase 1/2 Trial of Zigakibart in IgA Nephropathy. Poster. ASN Kidney Week. San Diego, California, US.
      8. 2024. Icodextrin Toxicity in a Patient with ESKD Secondary to Multiple Myeloma. Poster. ASN Kidney Week. San Diego, CA, US.
      9. 2024. New Electrolyte Derangements in Patients Treated for Cancer. Invited. ASN Kidney Week. San Diego, California, US.
      10. 2024. Hypophosphatemia in Cancer Therapy: Prevalence, Mechanisms, and Complications. Invited. ASN Kidney Week. San Diego, CA, US.
      11. 2022. A Case of Immune Checkpoint Inhibitor Related Osmotic Tubular Injury. Poster. ASN Kidney Week. Orlando, FL, US.
      12. 2022. Updated Interim Results of a Phase 1/2 Study of BION-1301 in Patients With IgA Nephropathy. Poster. ASN Kidney Week. Orlando, FL, US.
      13. 2022. Conducting an Ultrasound Guided Kidney Biopsy Workshop in Leon, Nicaragua. Poster. ASN Kidney Week. Orlando, FL, US.
      14. 2022. Baseline Characteristics of Renal Biopsy Cohort of Patients With CKDu in Nicaragua. Poster. ASN Kidney Week. Orlando, FL, US.
      15. 2021. Double Hit: A Case of Chromogranin A-Mediated Proximal Tubulopathy That Progressed to Full-Blown Fanconi Syndrome After Treatment with Everolimus. Poster. ASN Kidney Week, US.
      16. 2021. Admission Sodium and Related Features to Predict Falls in Machine Learning Models. Poster. ASN Kidney Week, US.
      17. 2020. Atypical Hemolytic Uremic Syndrome Attributed to Complement Dysregulation in Setting of Metastatic Prostate Cancer Patient. Poster. ASN Kidney Week. On-Demand, US.
      18. 2019. Checkpoint Inhibitors: The Double-Edged Sword in Kidney Transplant Patients. Poster. ASN Kidney Week. Washington, D.C, US.
      19. 2018. Myeloma-Like Cast Nephropathy in a Patient with Pancreatic Mixed Acinar-Neuroendocrine Cancer. Poster. ASN Kidney Week. San Diego, CA, US.
      20. 2018. Teaching Communications Skills in Nephrology Utilizing Sociodrama. Poster. ASN Kidney Week. San Diego, CA, US.
      21. 2017. Nephrotoxicity of Immune Checkpoint Inhibitors: MD Anderson Cancer Center’s Experience. Poster. ASN Kidney Week. New Orleans, LA, US.
      22. 2017. Relationship of Magnesium and Insulin Resistance in Living Donor Kidney Transplant Recipients. Poster. ASN Kidney Week. New Orleans, LA, US.
      23. 2017. Metabolic Responses to Kidney Transplantation: Is Early Weight Gain Benign?. Poster. ASN Kidney Week. New Orleans, LA, US.
      24. 2016. Adverse Weight Gain after Kidney Transplantation. Poster. ASN Kidney Week. Chicago, IL, US.
      25. 2016. Diabetic Nephropathy - An Update. Invited. Marriott Texas Medical Center. Houston, TX, US.
      26. 2012. Merits of Intraperitoneal Nutrition. Invited. US Renal Advisory Meeting, US.
      27. 2007. The Role of Senescence in Chronic Allograft Nephropathy. Invited. Young Investigator's Forum, US.

      Formal Peers

      1. 2019. Onco-Nephrology Emergencies. Visiting, US.
      2. 2019. Electrolyte Disturbance in Cancer Patients. Visiting, US.
      3. 2018. Fluid and Electrolyte Disorders in Cancer Patients. Visiting. Milan, IT.
      4. 2018. Adverse Metabolic Responses Following Kidney Transplantation Stimulate the Production of Visceral Adipose Tissue. Visiting, US.
      5. 2017. Onco-Nephrology. Visiting, US.
      6. 2017. Diabetic Nephrology. Visiting, US.
      7. 2016. Diabetic Nephrology. Visiting, US.
      8. 2015. Acute Kidney Injury: Diagnosis, Classification & Management. Visiting, US.
      9. 2015. Acute Kidney Injury: Novel Biomarkers. Visiting, US.
      10. 2014. Everything You Wanted to Know about Dialysis. Visiting, US.
      11. 2014. Kt/V, the 5-syllable Conundrum. Visiting, US.
      12. 2013. Sickle Cell Nephropathy. Visiting, US.
      13. 2012. Clinicopathologic Conference. Visiting, US.
      14. 2012. Merits of Intraperitoneal Nutrition. Visiting, US.
      15. 2012. Transitioning from Pediatric to Adult Nephrology. Visiting, US.
      16. 2008. Clinicopathologic Conference. Visiting, US.
      17. 2008. Glomerular Structure, Number and Function in Aging Cadaveric Donors. Visiting, US.
      18. 2007. The Role of Senescence in Chronic Allograft Nephropathy. Visiting, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2020 - Present
      Title:Educating community Nephrologist about Methotrexate Toxicity
      Funding Source:Boston Scientific Educational Grant
      Role:Program Leader
      Date: 2019 - 2019
      Title:Faculty and Trainee Education about Cell-Free DNA for the early detection of Organ Rejection
      Funding Source:Care-DX Educational Grant
      Role:Program Leader
      Date: 2017 - 2018
      Title:L-arginine for Anti-VEGF Induced Kidney Injury
      Funding Source:MD Anderson Cancer Center
      Role:Co-I
      ID:NCI Trial ID: NCI-2018-02537
      Date: 2016 - 2018
      Title:Managing Chemotherapy Induced Neuropathy in Cancer Patients using ExerGaming
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2015 - 2015
      Title:Efficacy and Safety of Tolvaptan in Subjects with Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
      Funding Source:Ostuka
      Role:PI
      Date: 2014 - 2015
      Title:Credence Study, Effects of Canagliflozin on Renal and Cardiovascular Outcomes
      Funding Source:Janssen
      Role:PI
      Date: 2014 - 2018
      Title:Supplemental Support for Examining Body Compositional Changes and Energy Metabolism after Kidney Transplantation
      Funding Source:Selzman Foundation for Kidney Research Career Development Recipient
      Role:PI
      Date: 2014 - 2018
      Title:Examining Body Compositional Changes and Energy Metabolism after Kidney Transplantation
      Funding Source:Roche Foundation Grant
      Role:PI
      Date: 2013 - 2015
      Title:A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide with Insulin Glargine on Glycemic Control in Patients with Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
      Funding Source:Ely Lilly
      Role:PI
      Title:Effect of Sodium Zirconium Cyclosilicate on the Reduction of Potassium in Patients with Tumor Lysis Syndrome: A Pilot Pragmatic Randomized Clinical Trial
      Funding Source:Astrazeneca
      Role:Investigator

      Selected Publications

      Peer-Reviewed Articles

      1. Lentini, P, Whitman, A, Jaimes, EA, Forni, LG, Cosmai, L, Perazella, MA, Ballen, K, Renaghan, AM, Fenoglio, R, Floris, M, Gladstone, DE, Glezerman, I, Goldstein, SL, Gupta, S, Herrmann, SM, Jhaveri, KD, Karam, S, Kitchlu, A, Landau, H, Latcha, S, Leaf, DE, Malyszko, J, Markowitz, G, Murakami, N, Ostermann, M, Pani, A, Rashidi, A, Roccatello, D, Ronco, C, Rosner, M, Sharon, E, Sprangers, B, Tesar, V, Torres, V, Wanchoo, R, Workeneh, BT, Zepeda-Orozco, D. Conventional cytotoxic chemotherapy–associated nephrotoxicity. Kidney International 109(6):1114-1124, 2026. e-Pub 2026. PMID: 41881107.
      2. Cintrón-García, JJ, Patel, M, Andersen, C, Page, VD, Workeneh, BT, Mandayam, S, Al-Dallal, R, Abudayyeh, A, Mamlouk, O. Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes Mellitus. Kidney International Reports 11(6), 2026. e-Pub 2026. PMID: 42179813.
      3. Renaghan, AM, Ostermann, M, Ronco, C, Ballen, K, Cosmai, L, Fenoglio, R, Floris, M, Forni, LG, Gladstone, DE, Glezerman, I, Goldstein, SL, Gupta, S, Herrmann, SM, Jaimes, EA, Jhaveri, KD, Karam, S, Kitchlu, A, Landau, H, Latcha, S, Leaf, DE, Lentini, P, Malyszko, J, Markowitz, G, Murakami, N, Pani, A, Perazella, MA, Rashidi, A, Roccatello, D, Sharon, E, Sprangers, B, Tesar, V, Torres, V, Wanchoo, R, Whitman, A, Workeneh, BT, Zepeda-Orozco, D, Rosner, M. The nephrotoxic effects of anti-cancer therapies. Nature Reviews Nephrology 22(4):283-300, 2026. e-Pub 2026. PMID: 41361704.
      4. Trachtman, H, Kretzler, M, Gesualdo, L, Cross, N, Workeneh, BT, Kaufeld, J, Meijers, B, Ye, Z, Chen, QK, Derebail, VK, Ng, MY, Ji, B, Lobmeyer, MT, Retlich, S, Licarião Rocha, FT, Prasad, S, Soleymanlou, N. TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis. The Lancet 407(10528):587-598, 2026. e-Pub 2026. PMID: 41616795.
      5. Kooienga, LA, Lo, J, Lee, EY, Kim, SG, Thomas, H, Workeneh, BT, Agha, I, Song, Y, Smith, W, van Eenennaam, H, Van Elsas, A, Dulos, J, Barratt, J. Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy. Kidney International 108(3):445-454, 2025. e-Pub 2025. PMID: 40482854.
      6. Wagner CA, Massy ZA, Capasso G, Mattace-Raso F, Pepin M, Bobot M, Zoccali C, Ferreira AC, Hoorn EJ, Silva PHI, Unwin RJ, Pesic V. Translational research on cognitive impairment in chronic kidney disease. Nephrol Dial Transplant, 2024. e-Pub 2024. PMID: 39400744.
      7. Rovin, BH, Barratt, J, Heerspink, HJ, Alpers, C, Bieler, S, Chae, DW, Diva, U, Floege, J, Gesualdo, L, Inrig, J, Kohan, DE, Komers, R, Kooienga, LA, Lafayette, RA, Maes, B, Malecki, R, Mercer, A, Noronha, IL, Oh, SW, Peh, CA, Praga, M, Preciado, P, Radhakrishnan, J, Rheault, MN, Rote, W, Tang, SC, Tesar, V, Trachtman, H, Trimarchi, H, Tumlin, JA, Wong, MG, Perkovic, V, Abbasciano, I, Abrantes, C, Accarino, S, Adler, SG, Adoberg, A, Afsari, R, Ahmad, S, Ahmed, J, Ahn, W, Ajayi, B, Aksamit, D, Al Chalabi, S, Alamartine, E, Alchi, B, Ali, M, Aliotta, R, Mandayam, S, Workeneh, BT. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT). The Lancet 402(10417):2077-2090, 2023. e-Pub 2023. PMID: 37931634.
      8. Heerspink, HJ, Radhakrishnan, J, Alpers, C, Barratt, J, Bieler, S, Diva, U, Inrig, J, Komers, R, Mercer, A, Noronha, IL, Rheault, MN, Rote, W, Rovin, B, Trachtman, H, Trimarchi, H, Wong, MG, Perkovic, V, Alarmartine, E, Chae, DW, Del Vecchio, L, Floege, J, Hwang, SJ, Jelakovic, B, Maes, B, Malecki, R, Miglinas, M, Nolasco, FB, Praga, M, Rabindranath, K, Rosenberg, M, Tang, SC, Tesar, V, Bose, B, Gangadharan, M, McDonald, SP, Peh, C, Jahan, S, Yeap, C, Clayton, P, Irish, G, Thyagarajan, N, Hollett, P, Krishnasamy, R, Carroll, R, Jesudason, S, Crail, S, Coates, T, Waugh, J, Mandayam, S, Workeneh, BT. Sparsentan in patients with IgA nephropathy. The Lancet 401(10388):1584-1594, 2023. e-Pub 2023. PMID: 37015244.
      9. Carstens MH, García N, Mandayam S, Workeneh B, Pastora I, Calderón C, Bertram KA, Correa D. Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy). Stem Cells Transl Med 12(1):7-16, 2023. e-Pub 2023. PMID: 36545894.
      10. Rashidi Jhaveri KD, Workeneh BT, Gupta S. The path toward the creation of the American Society of Onco-Nephrology. Journal of Onco-Nephrology. e-Pub 2022.
      11. Uppal N, Workeneh BT, Rondon-Berrios H, Jhaveri K. Electrolyte and Acid-Base Disorders associated with Cancer Immunotherapy. Clin J Am Soc Nephrol. e-Pub 2022.
      12. Adhikari S, Mamlouk O, Rondon-Berrios H, Workeneh BT. Hypophosphatemia in cancer patients. Clin Kidney J 14(11):2304-2315, 2021. e-Pub 2021. PMID: 34754427.
      13. Workeneh BT, Kalantar-Zadeh K, Moore LW. Progress in the Identification and Management of Protein-Energy Wasting and Sarcopenia in Chronic Kidney Disease. J Ren Nutr. e-Pub 2021. PMID: 34053819.
      14. Kang GE, Murphy TK, Kunik ME, Badr HJ, Workeneh BT, Yellapragada SV, Sada YH, Najafi B. The Detrimental Association between Fear of Falling and Motor Performance in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy. Gait & Posture, 2021. e-Pub 2021. PMID: 34091147.
      15. Adhikari S, Mamlouk O, Rondon-Berrios H, Workeneh BT. Hypophosphatemia in Cancer. Clinical Kidney Journal, 2021. e-Pub 2021.
      16. Workeneh BT, Mandayam S. Promoting Peritoneal Dialysis Retention in Underserved Communities. Am J Med Sci 361(1):1-2, 2021. e-Pub 2021. PMID: 33422190.
      17. Sada YH, Poursina O, Zhou H, Workeneh BT, Maddali SV, Najafi B. Harnessing digital health to objectively assess cancer-related fatigue: The impact of fatigue on mobility performance. PLoS One 16(2):e0246101, 2021. e-Pub 2021. PMID: 33636720.
      18. Tantisattamo E, Ho B, Workeneh BT. Metabolic Changes after Kidney Transplantation. Front Med. e-Pub 2021. PMID: 34307432.
      19. Tantisattamo E, Ho BT, Workeneh BT. Editorial: Metabolic Changes After Kidney Transplantation. Front Med (Lausanne) 8:709644, 2021. e-Pub 2021. PMID: 34307432.
      20. Pandey RK, DiPippo A, Kadia T, Pemmaraju N, Workeneh BT, Jabbour E, Ravandi F, Jain N. Nelarabine-related rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia. Leuk Lymphoma:1-3. e-Pub 2020. PMID: 32654562.
      21. Workeneh B, Jhaveri K, Rondon-Berrios. Hypomagnesemia in Cancer Patients. Kidney 360, 2020. e-Pub 2020.
      22. Workeneh B, Moore LW, Nolte Fong JV, Shypailo R, Gaber AO, Mitch WE. Successful Kidney Transplantation Is Associated With Weight Gain From Truncal Obesity and Insulin Resistance. J Ren Nutr. e-Pub 2019. PMID: 30852120.
      23. Strati P, Glass WF, Abdelrahim M, Selamet U, Tchakarov A, Workeneh BT, Verstovsek S, Abudayyeh A. Renal complications of primary myelofibrosis. Leuk Lymphoma 60(2):1-4, 2019. e-Pub 2019. PMID: 29966471.
      24. Zahiri M, Chen KM, Zhou H, Nguyen H, Workeneh BT, Yellapragada SV, Sada YH, Schwenk M, Najafi B. Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN. J Geriatr Oncol. e-Pub 2019. PMID: 30665876.
      25. Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immunother Cancer 7(1):2, 2019. e-Pub 2019. PMID: 30612580.
      26. Ahmed S, Guffey D, Minard C, Workeneh B. Efficacy of loop diuretics in the management of undocumented patients with end-stage renal disease. Am J Emerg Med 34(8):1552-5, 2016. e-Pub 2016. PMID: 27260551.
      27. Ahmed S, Truong LD, Workeneh B. Fraternal twins with job's syndrome and immune complex nephritis. CEN Case Rep 5(1):61-66, 2016. e-Pub 2016. PMID: 28509165.
      28. Razzak Chaudhary S, Workeneh BT, Montez-Rath ME, Zolopa AR, Klotman PE, Winkelmayer WC. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant 30(10):1734-40, 2015. e-Pub 2015. PMID: 26175146.
      29. Zhou X, Workeneh B, Hu Z, Li R. Effect of immunosuppression on the human mesangial cell cycle. Mol Med Rep 11(2):910-6, 2015. e-Pub 2015. PMID: 25370945.
      30. Workeneh B, Guffey D, Minard CG, Mitch WE. Causes for Withdrawal in an Urban Peritoneal Dialysis Program. Int J Nephrol 2015:652953, 2015. e-Pub 2015. PMID: 26064683.
      31. Workeneh B, Shypailo R, DeCastro I, Shah M, Guffey D, Minard CG, Mitch WE. Adverse Effects of Sporadic Dialysis on Body Composition. Nephron 131(1):73-7, 2015. e-Pub 2015. PMID: 26314556.
      32. Peck BW, Workeneh B, Kadikoy H, Abdellatif A. Sodium hypochlorite-induced acute kidney injury. Saudi J Kidney Dis Transpl 25(2):381-4, 2014. e-Pub 2014. PMID: 24626008.
      33. Shah MK, Workeneh B, Taffet GE. Hypernatremia in the geriatric population. Clin Interv Aging 9:1987-92, 2014. e-Pub 2014. PMID: 25429210.
      34. Workeneh B, Mitch WE. High-protein diet in diabetic nephropathy: what is really safe?. Am J Clin Nutr 98(2):266-8, 2013. e-Pub 2013. PMID: 23824718.
      35. Shypailo R, Workeneh B, Ellis K. Assessment of the associated particle prompt gamma neutron activation technique for total body nitrogen measurement in vivo. J Radioanal Nucl Chem 296(1):143-148, 2013. e-Pub 2013.
      36. Workeneh B, Sangsiraprapha W, Addison D, Longfield E. A novel case of persistent Bartters-like syndrome associated with gentamicin exposure. Saudi J Kidney Dis Transpl 24(1):144-6, 2013. e-Pub 2013. PMID: 23354214.
      37. Xu J, Li R, Workeneh B, Dong Y, Wang X, Hu Z. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486. Kidney Int 82(4):401-11, 2012. e-Pub 2012. PMID: 22475820.
      38. Ahmed S, Truong L, Eknoyan G, Workeneh B. Evolving spectrum of HIV-associated nephropathy. Nephron Clin Pract 121(3-4):c131-5, 2012. e-Pub 2012. PMID: 23208246.
      39. Peck B, Workeneh B, Kadikoy H, Patel SJ, Abdellatif A. Spectrum of sodium hypochlorite toxicity in man-also a concern for nephrologists. NDT Plus 4(4):231-5, 2011. e-Pub 2011. PMID: 25949487.
      40. Peck B, Workeneh B, Kadikoy H, Abdellatif A. Accidental Exposure to sodium hypochlorite causing acute kidney injury. SJKDT, 2011. e-Pub 2011.
      41. Tan JC, Busque S, Workeneh B, Ho B, Derby G, Blouch KL, Sommer FG, Edwards B, Myers BD. Effects of aging on glomerular function and number in living kidney donors. Kidney Int 78(7):686-92, 2010. e-Pub 2010. PMID: 20463656.
      42. Workeneh B, Abbasi F, Reaven G. Fasting urine pH is independent of insulin sensitivity. Am J Clin Nutr 91(3):586-8, 2010. e-Pub 2010. PMID: 20032494.
      43. Tan JC, Workeneh B, Busque S, Blouch K, Derby G, Myers BD. Glomerular function, structure, and number in renal allografts from older deceased donors. J Am Soc Nephrol 20(1):181-8, 2009. e-Pub 2009. PMID: 18815243.
      44. Workeneh B, Mireles M. Implementation of the MediSend Program: a multidisciplinary medical surplus recovery initiative at an academic health science center. Sustainability: Science, Practice and Policy 3(1), 2007. e-Pub 2007.
      45. Workeneh BT, Rondon-Berrios H, Zhang L, Hu Z, Ayehu G, Ferrando A, Kopple JD, Wang H, Storer T, Fournier M, Lee SW, Du J, Mitch WE. Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol 17(11):3233-9, 2006. e-Pub 2006. PMID: 17005936.
      46. Workeneh B, Balakumaran A, Bichet DG, Mitch WE. The dilemma of diagnosing the cause of hypernatremia: drinking habits vs diabetes insipidus. Nephrol Dial Transplant 19(12):3165-7, 2004. e-Pub 2004. PMID: 15575005.
      47. Workeneh B, Balakumaran A, Mitch WE. A case of severe hypernatremia uncovers partial diabetes insipidus. Nephrol Dialysis and Trans 58(1):19-23, 2004. e-Pub 2004.

      Review Articles

      1. Rashidi, A, Youssef, N, Workeneh, BT, Carsel, A, Gutgarts, V, Latcha, S. Electrolytes Abnormalities in Cancer Patients. American Journal of Nephrology 57(2):193-208, 2026. e-Pub 2026. PMID: 39999798.
      2. Xu, H, Eriksdotter, M, Hafez, G, Mitra, S, Bruchfeld, A, Pešić, V, Unwin, R, Wagner, CA, Massy, ZA, Zoccali, C, Pepin, M, Capasso, G, Liabeuf, S, Capasso, G, Andrade, A, Arici, M, Bachmann, M, Bailey, M, Barbieri, M, Bobot, M, Bruchfeld, A, Arune-Bumblyte, I, Rastenyte, D, Calcutta, A, Capolongo, G, Carriazo, S, Ceccarelli, M, Constantin Covic, A, De, A, Delgado, P, Endlich, N, Endres, M, Esposito, F, Farisco, M, Faucher, Q, Ferreira, AC, Figurek, A, Fouque, D, Franssen, C, Fridolin, I, Frische, S, Garneata, L, Gesualdo, L, Giannakou, K, Godefroy, O, Golenia, A, Goumenos, D, Jiménez, EG, Hafez, G, Hoorn, EJ, Silva, PI, Izhar, R, Kelly, D, Kesler, S, Klimkowicz-Mrowiec, A, Knauss, S, Kurganaite, J, Levassort, H, Liabeuf, S, Malyszko, J, Mani, LY, Martino, G, Massy, Z, Mayer, C, Mucci, A, Mutevelic-Turkovic, A, Nielsen, R, Nitsch, D, Ortiz, A, Panagiotopoulos, V, Karasavvidou, D, Paolisso, G, Pejušković, B, Pepin, M, Perna, A, Perrottelli, A, Pešić, V, Pezzella, P, Rroji molla, M, Rychlík, I, Sakkas, G, Simeoni, M, Romeo, MS, Spasovski, G, Starčević, A, Tedeschi, G, Trevisani, F, Unwin, R, Vazelov, E, Wagner, CA, Wagner, F, Wanner, C, Wiecek, A, Xu, H, Zacchia, M, Zacharia, L, Zecchino, I, Zoccali, C, Mattace-Raso, FU, Endlich, K, Perico, N, Remuzzi, G, Trepiccione, F, Okusa, M, Marzo, VD, Blankestijn, PJ, Eckardt, KU, Konig, M, Gansevoort, RT, Askari, H, Hansen, B, Snaedal, S, Cuiban, E, Caporusso, E, Re, VL, Roiser, J, Rosenberg, K, Bisecco, A, Denby, L, Kulkarni, OP, Sharma, K, Debnath, S, Jaafar, A, Capasso, A, Mulholland, MM, Workeneh, BT, Iervolino, A, Fraser, S, Frey-Wagner, I, Pastore, A, Mačiulaitis, R, De Donato, A, Farinha, A. Cholinergic system in patients with chronic kidney disease. Nephrology Dialysis Transplantation 40(11):2026-2037, 2025. e-Pub 2025. PMID: 39919765.
      3. Simeoni M, Mulholland MM, Workeneh BT, Capasso A, Hafez G, Liabeuf S, Malyszko J, Mani LY, Trevisani F, De A, Wagner CA, Massy ZA, Unwin R, Capasso G. Chemotherapy-related cognitive impairment and kidney dysfunction. Nephrol Dial Transplant 40(Supplement_2):ii54-ii63, 2025. e-Pub 2025. PMID: 40080088.
      4. Zoccali, C, Mallamaci, F, Wagner, CA, Unwin, R, Nedergaard, M, Hafez, G, Malyszko, J, Pepin, M, Massy, ZA, Paolisso, G, Remuzzi, G, Capasso, G, Capasso, G, Andrade, A, Arici, M, Bachmann, M, Bailey, M, Barbieri, M, Bobot, M, Rastenyte, D, Bruchfeld, A, Arune-Bumblyte, I, Calcutta, A, Capolongo, G, Carriazo, S, Ceccarelli, M, Covic, AC, De, A, Delgado, P, Endlich, N, Endres, M, Esposito, F, Farisco, M, Faucher, Q, Ferreira, AC, Figurek, A, Fouque, D, Franssen, C, Fridolin, I, Frische, S, Garneata, L, Gesualdo, L, Giannakou, K, Godefroy, O, Golenia, A, Goumenos, D, Jiménez, EG, Hoorn, EJ, Mulholland, MM, Workeneh, BT. Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKD. Nephrology Dialysis Transplantation 40:ii64-ii75, 2025. e-Pub 2025. PMID: 40080085.
      5. Wagner, CA, Frey-Wagner, I, Ortiz, A, Unwin, R, Liabeuf, S, Suzumoto, Y, Iervolino, A, Stasi, A, Marzo, VD, Gesualdo, L, Massy, ZA, Capasso, G, Bachmann, M, Andrade, A, Arici, M, Bailey, M, Barbieri, M, Bobot, M, Bruchfeld, A, Arune-Bumblyte, I, Rastenyte, D, Calcutta, A, Capolongo, G, Carriazo, S, Ceccarelli, M, Covic, AC, De, A, Delgado, P, Endlich, N, Endres, M, Esposito, F, Farisco, M, Faucher, Q, Ferreira, AC, Figurek, A, Fouque, D, Franssen, C, Fridolin, I, Frische, S, Garneata, L, Giannakou, K, Godefroy, O, Golenia, A, Goumenos, D, Jiménez, EG, Hafez, G, Hoorn, EJ, Imenez Silva, PH, Mulholland, MM, Workeneh, BT. The role of the intestinal microbiome in cognitive decline in patients with kidney disease. Nephrology Dialysis Transplantation 40:ii4-ii17, 2025. e-Pub 2025. PMID: 40080091.
      6. Bolignano, D, Simeoni, M, Hafez, G, Pepin, M, Gallo, A, Altieri, M, Liabeuf, S, Giannakou, K, De Ananya, A, Capasso, G, Andrade, A, Arici, M, Bachmann, M, Bailey, M, Barbieri, M, Bobot, M, Bruchfeld, A, Arune-Bumblyte, I, Rastenyte, D, Calcutta, A, Capolongo, G, Carriazo, S, Ceccarelli, M, Covic, AC, Delgado, P, Endlich, N, Endres, M, Esposito, F, Farisco, M, Faucher, Q, Ferreira, AC, Figurek, A, Fouque, D, Franssen, C, Fridolin, I, Frische, S, Garneata, L, Gesualdo, L, Godefroy, O, Golenia, A, Goumenos, D, Jiménez, EG, Hoorn, EJ, Silva, PI, Izhar, R, Kelly, D, Kesler, S, Klimkowicz-Mrowiec, A, Mulholland, MM, Workeneh, BT. Cognitive impairment in CKD patients. Clinical Kidney Journal 18(2), 2025. e-Pub 2025. PMID: 40235626.
      7. Howard SC, Avagyan A, Workeneh B, Pui CH. Tumour lysis syndrome. Nat Rev Dis Primers 10(1):58, 2024. e-Pub 2024. PMID: 39174582.
      8. Alhamid, N, Sabbagh, B, Alsarraj, A, Lerma, EV, Caza, T, Workeneh, BT, Barrientos, J, Jhaveri, KD. Pitfalls of Current Diagnostic Criteria of Tumor Lysis Syndrome. Kidney and Blood Pressure Research 49(1):266-272, 2024. e-Pub 2024. PMID: 38471470.
      9. Chowdhury R, Turcotte AE, Rondon-Berrios H, Workeneh BT. Spurious Electrolyte and Acid-Base Disorders in the Patient With Cancer: A Review. Am J Kidney Dis 82(2):237-242, 2023. e-Pub 2023. PMID: 36906215.
      10. Workeneh BT, Meena P, Christ-Crain M, Rondon-Berrios H. Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice. Adv Kidney Dis Health 30(2):85-101, 2023. e-Pub 2023. PMID: 36868737.
      11. Bonilla, M, Workeneh, BT, Uppal, NN. Hypomagnesemia in Patients With Cancer. Seminars in Nephrology 42(6), 2022. e-Pub 2022. PMID: 37086496.
      12. Uppal, NN, Workeneh, BT, Rondon-Berrios, H, Jhaveri, KD. Electrolyte and Acid-Base Disorders Associated with Cancer Immunotherapy. Clinical Journal of the American Society of Nephrology 17(6):922-933, 2022. e-Pub 2022. PMID: 35063968.
      13. Ratanasrimetha P, Workeneh BT, Seethapathy H. Sodium and Potassium Dysregulation in the Patient With Cancer. Adv Chronic Kidney Dis 29(2):171-179.e1, 2022. e-Pub 2022. PMID: 35817524.
      14. Workeneh, BT, Uppal, NN, Jhaveri, KD, Rondon-Berrios, H. Hypomagnesemia in the Cancer Patient. Kidney360 2(1):154-166, 2021. e-Pub 2021. PMID: 35368816.
      15. Workeneh BT, Jhaveri KD, Rondon-Berrios H. Hyponatremia in the cancer patient. Kidney Int. e-Pub 2020. PMID: 32497528.
      16. Workeneh B, Bajaj M. The regulation of muscle protein turnover in diabetes. Int J Biochem Cell Biol 45(10):2239-44, 2013. e-Pub 2013. PMID: 23838169.
      17. Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr 91(4):1128S-1132S, 2010. e-Pub 2010. PMID: 20181807.

      Other Articles

      1. Howard, SC, Avagyan, A, Workeneh, BT, Pui, CH Publisher Correction. Nature Reviews Disease Primers 10(1), 2024. PMID: 39251620.

      Editorials

      1. Workeneh BT, Moore LW, Mitch WE. Revisiting Protein Restriction in Early CKD: Did We Get it Wrong?. Am J Kidney Dis 85(5):654-657, 2025. PMID: 39892462.

      Abstracts

      1. Mamlouk O, Workeneh B, Chen C, Mandayam S. Eosinophilic granulomatosis with polyangiitis in patient treated with chemokine receptor type 4 antibody. International Society of Nephrology. Abudhabi, UAE, 2020. e-Pub 2020.
      2. Anumudu S, Workeneh B. First Report of Successful Kidney Transplantation in a Patient with Job's Syndrome. National Kidney Foundation, 2019. e-Pub 2019.
      3. Nolte J, Workeneh B. Relationship of Magnesium and Insulin Resistance in Living Donor Kidney Transplant Recipients. American Society of Nephrology, 2017. e-Pub 2017.
      4. Workeneh B. Chemotherapy Induced Neuropathy in CKD Patients. American Society of Nephrology, 2017. e-Pub 2017.
      5. Workeneh B, Gaber AO, Mitch WE. Adverse Weight Gain after Kidney Transplantation. American Society of Nephrology, 2016. e-Pub 2016.
      6. Ahmed S, Workeneh B. Efficacy of Loop Diuretics in the Management of Undocumented ESRD patients. American Society of Nephrology, 2015. e-Pub 2015.
      7. Ahmed S, Minard C, Guffy D, Workeneh B. Effect of loop diuretics in ER utilization rates among emergent dialysis. Baylor Symposium, 2014. e-Pub 2014.
      8. Shah M, DeCastro I, Workeneh B. Sickle Cell Trait as Risk Factor for CKD. American Society of Nephrology, 2014. e-Pub 2014.
      9. Workeneh B, Mandayam S, Mitch WE. Causes of Peritoneal Dialysis Withdrawal in an Urban Peritoneal Dialysis Program. International Society of Peritoneal Dialysis, 2014. e-Pub 2014.
      10. Hothi J, Truong L, Workeneh B. Glomerular Changes in a Patient with Methylmalonic Acidemia. American Society of Nephrology, 2014. e-Pub 2014.
      11. Ahmed S, Truong L, Workeneh B. Job's Syndrome related Glomerulonephritis. American Society of Nephrology, 2014. e-Pub 2014.
      12. Shypailo R, Workeneh B, Ellis K. Assessment of the associated particle prompt gamma neutron activation technique for total body nitrogen measurement in vivo. 9th International Conference on Methods and Applications of Radioanalytical Chemistry, 2012. e-Pub 2012.
      13. Workeneh B, Mitch WE. Isotopic Imaging Methods to Determine Muscle Mass in Kidney Disease. American Society of Nephrology Annual Meeting, 2010. e-Pub 2010.
      14. Addison D, Workeneh B. Bartter's like syndrome induced by aminoglycoside treatment. Alexander BCM Research Symposium, 2010. e-Pub 2010.
      15. Workeneh B, Tan J, Busque S, Derby G, Blouch K, Meyers B. Reduced Glomerular Number a Contributes to Chronic Allograft Nephropathy. American Society of Transplantation Congress, 2008. e-Pub 2008.
      16. Workeneh B, Tan J, Busque S, Derby G, Blouch K, Meyers B. Role of Senescence in Chronic Allgraft Nephropathy. American Society of Nephrology Annual Meeting, 2007. e-Pub 2007.
      17. Workeneh B, Rondon H, Ferrando A, Du J, Mitch WE. Development of a diagnostic method for detecting increased muscle protein degradation in patients suffering from catabolic conditions including kidney failure. American Society of Nephrology Annual Meeting, 2004. e-Pub 2004.
      18. Rondon H, Workeneh B, Ferrando A, Du J, Mitch WE. A new method of diagnosing accelerated muscle breakdown in catabolic conditions: The utility of the 14kDa Actin Band. American Society of Nephrology Annual Meeting, 2004. e-Pub 2004.
      19. Workeneh B, Agraharkar M. Need for optimizing ESRD care. National Kidney Foundation Annual Meeting, 2004. e-Pub 2004.

      Book Chapters

      1. Workeneh B, Danesh F. OncoNephrology: An Emerging Discipline. In: Essentials of CKD. Third Edition, 2018.
      2. Workeneh B, Bajaj M. Nutritional Considerations in Diabetic Kidney Disease. In: Handbook of Renal Nutrition. Seventh Edition, 2016.
      3. Workeneh B. "Acute Kidney Injury: Classification and Prognosis". In: Essentials of CKD. Second Edition, 2015.
      4. Workeneh BT, Agraharkar M. Acute Kidney Injury. In: Medscape Reference, 2013.
      5. Workeneh B, Mitch WE. "Chronic Kidney Disease: Pathophysiology and Influence of Dietary Protein". In: Seldin and Giebisch's The Kidney: Physiology and Pathophysiology. Fifth Edition, 2013.
      6. Workeneh B, Mitch WE. "The Influence of Kidney Disease on Protein and Amino Acid Metabolism". In: Kopple and Massry's Nutritional Management of Renal Disease. Third Edition, 2012.
      7. Fulop T, Workeneh B, Agraharkar M, Fehlan M. Hypermagnesemia. In: Medscape Reference, 2012.
      8. Bejjanki H, Mamlouk O, Workeneh B. End-stage Kidney Disease and Malignancy. In: Issues in Kidney Disease. First Edition.
      9. Workeneh B, Mitch WE. The Influence of Kidney Disease on Protein and Amino Acid Metobolism. In: Nutritional Management of Renal Disease. Fourth Edition.
      10. Mamlouk B, Workeneh B. AKI In Malignancy. In: Issues in Kidney Disease. First Edition.

      Letters to the Editor

      1. Imran, N, Ayesh, A, Workeneh, BT, Shahait, A. Sodium Bicarbonate. American journal of therapeutics 31: e508-e510, 2024.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 10, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top